Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The consumption of antibiotics has increased significantly over the past 15 years, according to a recent study. The increase occurred despite the international push to reduce the use of these important drugs.

Researchers found that while many low- and middle-income countries still lack appropriate access to antibiotics, the global increase was driven largely by some developing countries which face more drug-resistant infections and a lack of tools to test infections and track how these medications are used.

To tackle antimicrobial resistance (AMR), we need to look at all the factors behind how and when antibiotics are used. One obstacle I often see as a medical microbiologist working in developing countries, is a lack of access to clean water, which makes preventing and controlling infections nearly impossible. It is a major driver of inappropriate antibiotic use and, ultimately, the growth in antibiotic-resistant bugs – so-called “superbugs”.

Read the full article on The Conversation website, written by Abhilasha Karkey (Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine). 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.

Oxford-led research maps milestone stage of human development for the first time

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.

Overusing antibiotics? Find out with Antibiotic Footprint Calculator

To help reduce the overuse of antibiotics, Oxford researchers today released a new, easy to use online tool – Antibiotic Footprint Calculator – that could make an important contribution in the fight against antimicrobial resistance (AMR), one of the world’s most significant emerging threats to public health.

$2m fund awarded for Oxford’s single-cell ancestry vaccine research

The University of Oxford is to benefit from $2 million (£1.49 million) in funding from the Chan Zuckerberg Initiative (CZI) to investigate how our ancestry and diversity influence the way that vaccines work in our cells.